Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 134

1.

Information on 'Overdiagnosis' in Breast Cancer Screening on Prominent United Kingdom- and Australia-Oriented Health Websites.

Ghanouni A, Meisel SF, Hersch J, Waller J, Wardle J, Renzi C.

PLoS One. 2016 Mar 24;11(3):e0152279. doi: 10.1371/journal.pone.0152279. eCollection 2016.

2.

The benefits and harms of breast cancer screening: an independent review.

Independent UK Panel on Breast Cancer Screening.

Lancet. 2012 Nov 17;380(9855):1778-86. doi: 10.1016/S0140-6736(12)61611-0. Epub 2012 Oct 30. Review.

PMID:
23117178
3.

The distribution of ductal carcinoma in situ (DCIS) grade in 4232 women and its impact on overdiagnosis in breast cancer screening.

van Luijt PA, Heijnsdijk EA, Fracheboud J, Overbeek LI, Broeders MJ, Wesseling J, den Heeten GJ, de Koning HJ.

Breast Cancer Res. 2016 May 10;18(1):47. doi: 10.1186/s13058-016-0705-5.

4.

Breast Cancer Screening in Denmark: A Cohort Study of Tumor Size and Overdiagnosis.

Jørgensen KJ, Gøtzsche PC, Kalager M, Zahl PH.

Ann Intern Med. 2017 Mar 7;166(5):313-323. doi: 10.7326/M16-0270. Epub 2017 Jan 10.

PMID:
28114661
5.

Benefit-to-harm ratio of the Danish breast cancer screening programme.

Beau AB, Lynge E, Njor SH, Vejborg I, Lophaven SN.

Int J Cancer. 2017 Aug 1;141(3):512-518. doi: 10.1002/ijc.30758. Epub 2017 May 10.

6.

Survey of public definitions of the term 'overdiagnosis' in the UK.

Ghanouni A, Meisel SF, Renzi C, Wardle J, Waller J.

BMJ Open. 2016 Apr 6;6(4):e010723. doi: 10.1136/bmjopen-2015-010723.

7.

"Well, have I got cancer or haven't I?" The psycho-social issues for women diagnosed with ductal carcinoma in situ.

De Morgan S, Redman S, White KJ, Cakir B, Boyages J.

Health Expect. 2002 Dec;5(4):310-8.

8.

[Ductal carcinoma in situ: the balance between over- and undertreatment].

Groen EJ, Elshof LE, Rutgers EJ, Winter-Warnars HA, Lips EH, Wesseling J.

Ned Tijdschr Geneeskd. 2016;160:A9773. Review. Dutch.

PMID:
27071361
9.

Diagnosis and management of ductal carcinoma in situ (DCIS).

Virnig BA, Shamliyan T, Tuttle TM, Kane RL, Wilt TJ.

Evid Rep Technol Assess (Full Rep). 2009 Sep;(185):1-549. Review.

10.

Overdiagnosis and overtreatment of breast cancer: estimates of overdiagnosis from two trials of mammographic screening for breast cancer.

Duffy SW, Agbaje O, Tabar L, Vitak B, Bjurstam N, Björneld L, Myles JP, Warwick J.

Breast Cancer Res. 2005;7(6):258-65. Epub 2005 Nov 10.

11.

Overdiagnosis among women attending a population-based mammography screening program.

Falk RS, Hofvind S, Skaane P, Haldorsen T.

Int J Cancer. 2013 Aug 1;133(3):705-12. doi: 10.1002/ijc.28052. Epub 2013 Feb 25.

12.

Screen detection of ductal carcinoma in situ and subsequent incidence of invasive interval breast cancers: a retrospective population-based study.

Duffy SW, Dibden A, Michalopoulos D, Offman J, Parmar D, Jenkins J, Collins B, Robson T, Scorfield S, Green K, Hall C, Liao XH, Ryan M, Johnson F, Stevens G, Kearins O, Sellars S, Patnick J.

Lancet Oncol. 2016 Jan;17(1):109-14. doi: 10.1016/S1470-2045(15)00446-5. Epub 2015 Dec 5. Erratum in: Lancet Oncol. 2016 Feb;17(2):e46.

13.

Digital mammography screening: weighing reduced mortality against increased overdiagnosis.

de Gelder R, Fracheboud J, Heijnsdijk EA, den Heeten G, Verbeek AL, Broeders MJ, Draisma G, de Koning HJ.

Prev Med. 2011 Sep;53(3):134-40. doi: 10.1016/j.ypmed.2011.06.009. Epub 2011 Jun 21.

PMID:
21718717
14.

Quantifying the potential problem of overdiagnosis of ductal carcinoma in situ in breast cancer screening.

Yen MF, Tabár L, Vitak B, Smith RA, Chen HH, Duffy SW.

Eur J Cancer. 2003 Aug;39(12):1746-54.

PMID:
12888370
15.

Comparing perceived clarity of information on overdiagnosis used for breast and prostate cancer screening in England: an experimental survey.

Ghanouni A, Renzi C, McBride E, Waller J.

BMJ Open. 2017 Aug 21;7(8):e015955. doi: 10.1136/bmjopen-2017-015955.

16.

An investigation of the quality of breast cancer information provided on the internet by voluntary organisations in Great Britain.

Ream E, Blows E, Scanlon K, Richardson A.

Patient Educ Couns. 2009 Jul;76(1):10-5. doi: 10.1016/j.pec.2008.11.019.

PMID:
19179036
17.

Overdiagnosis due to breast cancer screening: updated estimates of the Helsinki service study in Finland.

Heinävaara S, Sarkeala T, Anttila A.

Br J Cancer. 2014 Sep 23;111(7):1463-8. doi: 10.1038/bjc.2014.413. Epub 2014 Aug 14.

18.

Women's views on overdiagnosis in breast cancer screening: a qualitative study.

Hersch J, Jansen J, Barratt A, Irwig L, Houssami N, Howard K, Dhillon H, McCaffery K.

BMJ. 2013 Jan 23;346:f158. doi: 10.1136/bmj.f158.

19.
20.

Modelling the overdiagnosis of breast cancer due to mammography screening in women aged 40 to 49 in the United Kingdom.

Gunsoy NB, Garcia-Closas M, Moss SM.

Breast Cancer Res. 2012 Nov 29;14(6):R152. doi: 10.1186/bcr3365.

Supplemental Content

Support Center